alpha-L-Fucp-(1->3)-beta-D-GlcpNAc-(1->2)-D-Manp

Term ID

CHEBI:147017

Synonyms

6-deoxy-alpha-L-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->2)-D-manno-hexopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-D-mannopyranose
alpha-L-fucopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-D-mannopyranose
Fuc(a1-3)GlcNAc(b1-2)Man
N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[(3S,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide

Definition

An amino trisaccharide consisting of α-L-fucopyranosyl, 2-acetamido-β-D-glucosyl and D-mannopyranosyl residues linked in sequence by (1→3) and (1→2) glycosidic linkeages.

References

glygen:G06595MR
glytoucan:G06595MR
kegg.glycan:G01026

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->3)-beta-D-GlcpNAc-(1->2)-D-Manp

Phenotype where environments contain alpha-L-Fucp-(1->3)-beta-D-GlcpNAc-(1->2)-D-Manp

Phenotype modified by environments containing alpha-L-Fucp-(1->3)-beta-D-GlcpNAc-(1->2)-D-Manp

Phenotype affecting alpha-L-Fucp-(1->3)-beta-D-GlcpNAc-(1->2)-D-Manp

Human Disease Model